Pharmaceutical preparations for treatment of cancer and autoimmune diseases; pharmaceutical preparations for use in oncology, hematology, and the treatment of immunological disorders; pharmaceutical preparations used in synthetic lethal therapies for inducing destruction of diseased cells with DNA damage for medical treatment purposes.
Research and development of medical tests for analyzing synthetic lethality and DNA damage; research and development of synthetic lethal therapies and biomarkers of synthetic lethality; medical laboratory services; medical testing for scientific research purposes in the field of oncology, synthetic lethality, and DNA repair; providing medical and scientific research information in the fields of synthetic lethality, DNA repair, synthetic lethal therapies, oncology, hematology, and immunology; drug discovery services.
REGISTERED
on 28 Sep 2022
CYTEIR
CYTEIR THERAPEUTICS INC.
2021637 · 07 Jan 2020
005
Class 005
Pharmaceutical Products
Pharmaceutical preparations for treatment of cancer and autoimmune diseases; pharmaceutical preparations for use in oncology, hematology, and the treatment of immunological disorders; pharmaceutical preparations used in synthetic lethal therapies for inducing destruction of diseased cells with DNA damage for medical treatment purposes.
Research and development of medical tests for analyzing synthetic lethality and DNA damage; research and development of synthetic lethal therapies and biomarkers of synthetic lethality; medical laboratory services; medical testing for scientific research purposes in the field of oncology, synthetic lethality, and DNA repair; providing medical and scientific research information in the fields of synthetic lethality, DNA repair, synthetic lethal therapies, oncology, hematology, and immunology; drug discovery services.
Pharmaceutical preparations for treatment of cancer and autoimmune dis...
